Search ReproCELL Products
ReproCELL’s core technologies
ReproCELL has played a pivotal role in commercializing the leading stem cell technologies developed by Japanese academia and industry. We have put a number of unprecedented original technologies into the market by collaborating closely with our partners.
Reprogramming technology developed by Kyoto University
ReproCELL is the first company licensed to generate iPS cells by reprogramming from, which was established to advance healthcare through the transfer of the iPS technologies generated by Kyoto University. This made it possible for us to directly and quickly apply this innovative technology to applications in human health, by using it in combination with other world class technologies we have.
Human ES/iPS cell culture technology co-developed with Kyoto University
ReproCELL has commercialized culture medium for human ES/iPS cells as early as 2005. This medium was originally developed by company co-founderat Kyoto University. This medium, named because human iPS cells had not yet been invented, has supported the entire ES/iPS cell research field for more than 6 years. One of the most famous studies made possible by this product was at Kyoto University in 2007窶杯he team used Primate ES Cell Medium to establish the very first iPS cell line. ReproCELL has been continuously developing human ES/iPS cell culture technologies and has launched to help advance the field.
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.